WO2001070688A3 - N-(2,6-dioxo-piperidin-3-yl) benzamide und ihre verwendung als immunomodulatoren - Google Patents

N-(2,6-dioxo-piperidin-3-yl) benzamide und ihre verwendung als immunomodulatoren Download PDF

Info

Publication number
WO2001070688A3
WO2001070688A3 PCT/EP2001/002852 EP0102852W WO0170688A3 WO 2001070688 A3 WO2001070688 A3 WO 2001070688A3 EP 0102852 W EP0102852 W EP 0102852W WO 0170688 A3 WO0170688 A3 WO 0170688A3
Authority
WO
WIPO (PCT)
Prior art keywords
group
atoms
formula
chained
straight
Prior art date
Application number
PCT/EP2001/002852
Other languages
English (en)
French (fr)
Other versions
WO2001070688A2 (de
Inventor
Stefanie Frosch
Tieno Germann
Oswald Zimmer
Original Assignee
Gruenenthal Gmbh
Stefanie Frosch
Tieno Germann
Oswald Zimmer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2000113499 external-priority patent/DE10013499A1/de
Application filed by Gruenenthal Gmbh, Stefanie Frosch, Tieno Germann, Oswald Zimmer filed Critical Gruenenthal Gmbh
Priority to AU2001252196A priority Critical patent/AU2001252196A1/en
Publication of WO2001070688A2 publication Critical patent/WO2001070688A2/de
Publication of WO2001070688A3 publication Critical patent/WO2001070688A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/94—Oxygen atom, e.g. piperidine N-oxide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Es werden substituierte Benzamide in der R1 für eine Gruppe der Formel COOR4, in der R4 einen geradkettingen oder verweigten Alkylrest mit 1-6 C-Atomen darstellt, oder für eine Gruppe der Formel CONR5R6, in der R?5 und R6¿ gleich oder verschieden sind und eine Alkylgruppe mit 1-6 C-Atomen (geradekettig oder verzweigt) oder zusammen mit dem N-Atom einen Pyrrolidin-, Piperidin-, Hexamethylenimin- oder Morpholinring bedeuten, steht, R2 Chlor, Fluor, CF¿3?, einen Alkylrest mit 1-3 C-Atomen oder Wasserstoff bedeutet und R?3¿ die Hydroxygruppe, einen Alkyl- oder Alkoxyrest mit 1-6 C-Atomen (geradkettig oder verzweigt und gegebenenfalls substituiert mit OH-, Alkoxy-, Ester- oder Amidgruppen) oder einen Rest CH¿2-NR?5R6, in dem R?5 und R6¿ wie oben definiert sind, darstellt, dadurch gekennzeichnet, daß R1 für eine Gruppe der Formel COR4 wie oben definiert ist, und/oder R2 für die Aminogruppe steht und ihre Verwendung in Arzneimitteln, insbesondere als Immunmodulatoren, beschrieben.
PCT/EP2001/002852 2000-03-20 2001-03-14 N-(2,6-dioxo-piperidin-3-yl) benzamide und ihre verwendung als immunomodulatoren WO2001070688A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001252196A AU2001252196A1 (en) 2000-03-20 2001-03-14 Substituted benzamides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2000113499 DE10013499A1 (de) 1998-09-24 2000-03-20 Substituierte Benzamide
DE10013499.8 2000-03-20

Publications (2)

Publication Number Publication Date
WO2001070688A2 WO2001070688A2 (de) 2001-09-27
WO2001070688A3 true WO2001070688A3 (de) 2002-02-07

Family

ID=7635442

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/002852 WO2001070688A2 (de) 2000-03-20 2001-03-14 N-(2,6-dioxo-piperidin-3-yl) benzamide und ihre verwendung als immunomodulatoren

Country Status (2)

Country Link
AU (1) AU2001252196A1 (de)
WO (1) WO2001070688A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2862643B1 (fr) * 2003-11-20 2005-12-30 Oreal Utilisation cosmetique de n-hydroxy imides
FR2862642B1 (fr) * 2003-11-20 2006-01-27 Oreal Utilisation cosmetique de n-hydroxy imides

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0989121A1 (de) * 1998-09-24 2000-03-29 Grünenthal GmbH Substituierte Benzamide und ihre Verwendung als Immunmodulatoren

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0989121A1 (de) * 1998-09-24 2000-03-29 Grünenthal GmbH Substituierte Benzamide und ihre Verwendung als Immunmodulatoren

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CORRAL L G ET AL: "Differential Cytokine Modulation and T Cell Activation by Two Distinct Classes of Thalidomide Analogues That Are Potent Inhibitors of TNF-alpha", JOURNAL OF IMMUNOLOGY., vol. 163, no. 1, 1999, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, pages 380 - 386, XP002178194, ISSN: 0022-1767 *
DATABASE WPI Section Ch Week 200123, Derwent World Patents Index; Class B03, AN 2000-239332 *
MOLLER D R ET AL: "Inhibition of IL-12 Production by Thalidomide", JOURNAL OF IMMUNOLOGY,US,THE WILLIAMS AND WILKINS CO. BALTIMORE, vol. 159, no. 10, 1997, pages 5157 - 5161, XP002125907, ISSN: 0022-1767 *

Also Published As

Publication number Publication date
AU2001252196A1 (en) 2001-10-03
WO2001070688A2 (de) 2001-09-27

Similar Documents

Publication Publication Date Title
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
PT672658E (pt) Agentes antitromboticos
DE69434213D1 (de) Verwendung von Zusatzstoffen in Treibstoffzusammensetzungen
EP1222910A3 (de) Dentalmaterialien auf der Basis polyfunktioneller Amide
TR199802160T2 (xx) Ateroskleroz tedavisi i�in azetidinon t�revleri.
AU2323095A (en) Lactam derivatives useful for pharmaceutical purposes
DE69633722D1 (de) Stoffwechseleffekt von bestimmten glutation analogen
CA2121571A1 (fr) Nouveaux acides et esters phenoxy isobutyriques substitues
DK0934080T3 (da) 1,3-Bis-(N-lactamyl)propaner og deres farmaceutiske og kosmetiske anvendelse
ATE155685T1 (de) Derivate des 6-amino-octahydro-indolizintriols
WO2001070688A3 (de) N-(2,6-dioxo-piperidin-3-yl) benzamide und ihre verwendung als immunomodulatoren
FI970448A0 (fi) N-substituoituja 3-atsobisyklo(3.2.0)heptaanijohdannaisia,jotka ovat käyttökelpoisia neuroleptisina aineina
DE68927630D1 (de) Analoge von Peptrolsubstraten
DK0696585T3 (da) Nyt bisoxadiazolidinderivat
ZA895623B (en) Tetracyclic antidepressants
MX9709466A (es) Medicamento para inhibir el melanoma.
PL326554A1 (en) Derivatives of amine and thiourea and inhibitors of nitrogen oxide synthase
NZ318627A (en) Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors
MY105625A (en) Dye couplers.
PT86656A (pt) 5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amino-6h-1,3,4-thadiazine verfahren zu ihrer herstellung die sie enthaltenden arzneimittel und ihre verwendung
UA41348C2 (uk) Проліки 3-ацил-2-оксіндол-1-карбоксамідів та фармацевтична композиція
IT1241452B (it) Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono
ATE123025T1 (de) 2-amino-n-(((4-(aminocarbonyl)pyrimidin-2- yl>amino>alkyl>-pyrimidin-4- carbonsäureamidderivate, ihre herstellung und ihre anwendung in der therapeutica.
ES2062024T3 (es) Nuevo pentapeptido y un procedimiento para su preparacion.
AU6312694A (en) 2-aminopyrazine-5-carboxamide derivatives, their preparation and their application in therapeutics

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP